Avastin in Combination With Radiation and Temozolomide Followed by Avastin, Temozolomide, and Topotecan for Glioblastoma Multiformes and Gliosarcomas
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Bevacizumab (Primary) ; Temozolomide (Primary) ; Topotecan
- Indications Glioblastoma; Gliosarcoma
- Focus Therapeutic Use
- 07 Mar 2017 Planned End Date changed from 1 Jan 2017 to 1 Jul 2017.
- 12 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Jan 2017.
- 20 Jan 2016 Planned End Date changed from 1 Dec 2015 to 1 Jul 2016 as reported by ClinicalTrials.gov record.